ConductScience.org, home

Paper42884019PubMed

The Adult Neurogenesis Theory of Alzheimer's Disease Predicts Where Tauopathy Develops in the Brain.

Abbate C. Int J Mol Sci, 2026.

Cite this record

ConductScience Library. The Adult Neurogenesis Theory of Alzheimer's Disease Predicts Where Tauopathy Develops in the Brain. Papers, record 42884019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42884019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Adult Neurogenesis Theory of Alzheimer's Disease Predicts Where Tauopathy Develops in the Brain.
Journal
Int J Mol Sci
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-20

Source PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Abbate CCarlohttps://orcid.org/0000-0002-0368-3834

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
NeurogenesisMajor topic
TauopathiesMajor topic
BrainMajor topic
Humans
tau Proteins
Animals
Neurons

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Ricerca Corrente 2026; RRC-2026-23687902Fondazione Don Carlo Gnocchi ETSPubMed

Source PubMed

Download CSV of grants

References317

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114713290Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory.J Neurochem2003https://conductscience.org/library/papers/14713290PubMed
215851853Olfactory involvement in aging and Alzheimer's disease: an autopsy study.J Alzheimers Dis2005https://conductscience.org/library/papers/15851853PubMed
323208308The spectrum of disease in chronic traumatic encephalopathy.Brain2013https://conductscience.org/library/papers/23208308PubMed
438830849Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status.Nat Commun2024https://conductscience.org/library/papers/38830849PubMed
528347679Chronic Traumatic Encephalopathy: The cellular sequela to repetitive brain injury.J Clin Neurosci2017https://conductscience.org/library/papers/28347679PubMed
624904272GSK-3β, a pivotal kinase in Alzheimer disease.Front Mol Neurosci2014https://conductscience.org/library/papers/24904272PubMed
728410659Early-Onset Alzheimer Disease.Neurol Clin2017https://conductscience.org/library/papers/28410659PubMed
833061903Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer's Disease.Front Aging Neurosci2020https://conductscience.org/library/papers/33061903PubMed
923302773Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.Alzheimers Res Ther2013https://conductscience.org/library/papers/23302773PubMed
1028062563Pathology of Neurodegenerative Diseases.Cold Spring Harb Perspect Biol2017https://conductscience.org/library/papers/28062563PubMed
1128386764Roles of tau protein in health and disease.Acta Neuropathol2017https://conductscience.org/library/papers/28386764PubMed
1228662669Glial contributions to neurodegeneration in tauopathies.Mol Neurodegener2017https://conductscience.org/library/papers/28662669PubMed
1338638964Behavioral and dysexecutive variant of Alzheimer's disease: Insights from structural and molecular imaging studies.Heliyon2024https://conductscience.org/library/papers/38638964PubMed
1421705422Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease.Brain2011https://conductscience.org/library/papers/21705422PubMed
1535987901Earlier Alzheimer's disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading.Nat Commun2022https://conductscience.org/library/papers/35987901PubMed
1639939240Astrocyte and oligodendrocyte pathology in Alzheimer's disease.Neurotherapeutics2025https://conductscience.org/library/papers/39939240PubMed
1733432193Molecular characterization of selectively vulnerable neurons in Alzheimer's disease.Nat Neurosci2021https://conductscience.org/library/papers/33432193PubMed
1841478818Tau in Alzheimer's disease: Shaping the future patient journey.J Prev Alzheimers Dis2026https://conductscience.org/library/papers/41478818PubMed
1930532084Olfactory and other sensory impairments in Alzheimer disease.Nat Rev Neurol2019https://conductscience.org/library/papers/30532084PubMed
2025936874Endogenous neurogenic cell response in the mature mammalian brain following traumatic injury.Exp Neurol2016https://conductscience.org/library/papers/25936874PubMed

See all 317 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42884019

GET https://conductscience.org/api/papers/v1/42884019/references?page=2